Amyotrophic lateral sclerosis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(13 intermediate revisions by 4 users not shown)
Line 2: Line 2:
{{Amyotrophic lateral sclerosis}}
{{Amyotrophic lateral sclerosis}}


{{CMG}}
{{CMG}}{{AE}}{{MMJ}}


==Overview==
==Overview==
==Epidemiology and Demographics==
The incidence and prevalence of ALS are rising globally. More resources should be dedicated to the advancement of care and research of ALS.
*ALS is one of the most common neuromuscular diseases worldwide, and people of all races and ethnic backgrounds are affected.
 
*Between 1 to 2 people per 100,000 develop ALS each year . ALS most commonly strikes people between 40 and 60 years of age, but younger and older people can also develop the disease. Men are affected slightly more often than women.
=Epidemiology and Demographics=
===Incidence===
*The incidence of ALS is around 0.6-3.8 per 100000 person-years.
===Prevalance===
The prevalence of ALS is between 4.1-8.4 per 100000 person-years.
===Age Onset===
The median age of onset of ALS is between 51-66 years.
===Gender===
The male population is more commonly affected by ALS than females.
 
<ref name="pmid31361627">{{cite journal| author=Longinetti E, Fang F| title=Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. | journal=Curr Opin Neurol | year= 2019 | volume= 32 | issue= 5 | pages= 771-776 | pmid=31361627 | doi=10.1097/WCO.0000000000000730 | pmc=6735526 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31361627  }} </ref>


==References==
==References==
{{reflist|2}}
{{reflist|2}}
[[Category:Motor neuron disease]]
[[Category:Neurology]]
[[Category:Disease]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 21:04, 21 July 2021

Amyotrophic lateral sclerosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Amyotrophic lateral sclerosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Amyotrophic lateral sclerosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Amyotrophic lateral sclerosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Amyotrophic lateral sclerosis epidemiology and demographics

CDC on Amyotrophic lateral sclerosis epidemiology and demographics

Amyotrophic lateral sclerosis epidemiology and demographics in the news

Blogs on Amyotrophic lateral sclerosis epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Amyotrophic lateral sclerosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Overview

The incidence and prevalence of ALS are rising globally. More resources should be dedicated to the advancement of care and research of ALS.

Epidemiology and Demographics

Incidence

  • The incidence of ALS is around 0.6-3.8 per 100000 person-years.

Prevalance

The prevalence of ALS is between 4.1-8.4 per 100000 person-years.

Age Onset

The median age of onset of ALS is between 51-66 years.

Gender

The male population is more commonly affected by ALS than females.

[1]

References

  1. Longinetti E, Fang F (2019). "Epidemiology of amyotrophic lateral sclerosis: an update of recent literature". Curr Opin Neurol. 32 (5): 771–776. doi:10.1097/WCO.0000000000000730. PMC 6735526 Check |pmc= value (help). PMID 31361627.


Template:WH Template:WS